Results 141 to 150 of about 25,471 (263)

In vitro and in vivo postmarketing surveillance of valsartan, alone or in combination with amlodipine or hydrochlorthiazide, among Palestinian hypertensive patients

Therapeutics and Clinical Risk Management, 2016
Abdel Naser Zaid,1 Masshour Ghanem,2 Dua’a Shweiki,1 Hala Shtewi,1 Raja’ Shaheen,1 Sondos Al Helaly,1 Zeina Khayyat,1 Rowa’a Al Ramahi,1 Sa’ed H Zyoud1 1Department of Pharmacy, Faculty of Medicine & Health Sciences, An-Najah ...
Zaid AN, Ghanem M, Shweiki D, Shtewi H, Shaheen R, Al Helaly S, Khayyat Z, Al Ramahi R, Zyoud SH   +8 more
doaj  

Industry reneges on postmarketing trial commitments [PDF]

, 2003
Aaron Bouchie
openalex   +1 more source

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

Drug, Healthcare and Patient Safety, 2015
Michele Jara, Thomas Aquilina, Peter Aupperle, Adrian L Rabinowicz Acorda Therapeutics, Inc., Ardsley, NY, USA Background: Dalfampridine extended release tablets (dalfampridine-ER; prolonged-, modified, or sustained-release fampridine outside the US ...
Jara M, Aquilina T, Aupperle P, Rabinowicz AL   +3 more
doaj  

Regulating risks in pharmaceutical law : the need of an optimal interplay between products safety and products liability [PDF]

, 2011
Published online: 7 June 2011The aim of this paper is to call for the need of a theoretical model of pharmaceutical products safety in which the two systems of regulation and liability operate complementarily. The question is why two legal tools that are
RIZZI, Marco
core  

Results from a nationwide postmarketing cohort study of patients in Sweden treated with etanercept [PDF]

, 2004
Nils Feltelius
openalex   +1 more source

Postmarketing Surveillance: Review of Open Sources of Drug Safety Data

Безопасность и риск фармакотерапии
INTRODUCTION. Postmarketing surveillance is the main mechanism to monitor and evaluate the safety of drugs approved for widespread clinical use. This mechanism provides up-to-date information on adverse drug reactions and facilitates the implementation ...
E. V. Shubnikova
doaj   +1 more source

Postmarketing Safety Surveillance for Typhoid Fever Vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002 [PDF]

, 2004
Elizabeth Begier, Dale R. Burwen, Penina Haber, Robert Ball   +3 more
openalex   +1 more source

Systematic review about data quality and protocol compliance in clinical trials [PDF]

, 2008
Bei Investigator Initiated Trials (IITs) werden alternative risikoadaptierte Monitoring-Strategien in Abhängigkeit vom individuellen Studiendesign und dem Risikoprofil diskutiert, um bei oft restriktiven Ressourcen eine den gesetzlichen Vorgaben ...
Brosteanu, Oana, Houben, Peggy, Ihrig, Kristina, Meyer, Sandra, Ohmann, Christian, Paulus, Ursula, Pfistner, Beate, Schwarz, Gabriele, Strenge-Hesse, Anke, Zettelmeyer, Ulrike   +9 more
core   +1 more source

Postmarketing Surveillance for Ultracet® (Tramadol 37.5mg/Acetaminophen 325mg) [PDF]

, 2004
Hye‐Soon Lee
openalex   +1 more source

The Respective Roles of Controlled Clinical Trials and Cohort Monitoring Studies in the Pre- and Postmarketing Assessment of Drugs [PDF]

, 2005
Muriel Vray, Bernard Hamelin, Patrice Jaillon, Michel Andréjak, Robert Benamouzig, Jean‐Paul Boissel, C. Bremard-Oury, Catherine Brun-Strang, E. Caulin, Dominic Cellier, Dominique Costagliola, Véronique Daurat, Abdelkader El Hasnaoui, Jean‐Marie Goehrs, Bettina A. Hamelin, Patrice Jaillon, Chrystel Jouan-Flahault, J L Montastruc, Nathan Moore, Alain Puech, M. Ricatte, P. Ricordeau, Marie-Hélène Rodde-Dunet, E. Rouffiac, Tabassome Simon, P Simon, A. Spriet, Éric Van Ganse, Patrick Vélicitat, Muriel Vray   +29 more
openalex   +1 more source